Thursday, February 6, 2025

Marc ZERBOLA CHALLANDE

193 POSTS
Marc has been involved in the Stock Market Media Industry for the last +5 years. After obtaining a college degree in engineering in France, he moved to Canada, where he created Money,eh?, a personal finance website.

Exclusive articles:

Nvidia Earnings on the Horizon: What to Watch for Ahead of Wednesday’s Report

Nvidia Corporation (NVDA), the reigning titan in the AI chip market, is set to release its fiscal Q3 2024 earnings on November 20. Analysts...

Mayday, The USS “Stock Market” is Getting Attacked

The stock market, particularly in the pharmaceutical and energy sectors, has been reacting strongly to the news surrounding the nomination of Robert F. Kennedy...

Should You Fear Trump at the Head of the USA?

With the possibility of Donald Trump leading the United States once again, significant economic and environmental policies are poised for potential change. Trump’s transition...

Should You Invest in RenovoRX Now?

RenovoRx (RNXT) is a life sciences company at the forefront of developing targeted oncology therapies aimed at addressing unmet medical needs in cancer treatment....

Potential Trade Tensions in Asia as U.S. Tariffs Loom Under Trump 2.0

The re-election of Donald Trump as U.S. president has revived the prospect of heightened tariffs on Chinese imports. However, China might not be the...

Breaking

NurExone: Pioneering Exosome Therapies for Vision and Spinal Cord Regeneration

NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the...

How the Uranium Market Will Be Impacted by Trump’s Policy

As global energy policies evolve, the uranium market is...

Why Markets Are Skittish About Trump’s Tariff Policy

In recent years, the announcement of new tariff policies...

NurExone Biologic Inc. and Its Competitors in Regenerative Medicine and Spinal Cord Injury Treatment

Regenerative medicine is revolutionizing the treatment of severe neurological...
spot_img